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[57] ABSTRACT 
Qualitative transcriptional regulatory sequences functional 
in plants, plant tissue and in plant cells for inducible gene 
expression and quantitative transcriptional regulatory 
sequences for increasing the transcriptional expression of 
downstream genetic information in plants, plant tissue and 
plant cells are disclosed. Also disclosed are methods and 
recombinant DNA molecules for improving the disease 
resistance of transgenic plants, especially Wherein an induc 
ible promoter controls the expression of a protein capable of 
evoking the hypersensitive response in a plant. 
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PATHOGEN-INDUCIBLE REGULATORY 
ELEMENT 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation-in-part of Ser. No. 
08/471,983 ?led on Jun. 6, 1995, noW abandoned, Which is 
a continuation of Ser. No. 08/443,639, Which Was ?led on 
May 18, 1995, the disclosures of Which are hereby incor 
porated by reference. 
STATEMENT AS TO FEDERALLY SPONSORED 
RESEARCH 
This invention Was made, at least in part, With funding 
from the National Science Foundation and the United States 
Department of Agriculture. Accordingly, the United States 
Government may have certain rights in this invention. 
1. The Field of the Invention 
The ?eld of this invention is the area of plant molecular 
biology, and it relates in particular to transcription regulatory 
elements: a qualitative regulatory sequence Which positively 
regulates doWnstream gene expression in plant tissue in 
response to the stress of an invading microbial pathogen, an 
elicitor, or other inducing chemical signals and quantitative 
regulatory sequences Which increase the transcriptional 
expression of associated sequences. 
2. The Background of the Invention 
In plants, disease resistance to fungal, bacterial, and viral 
pathogens is associated With a plant response termed the 
hypersensitivity response In the HR, the site in the 
plant Where the potential phytopathogen invades undergoes 
localiZed cell death, and it is postulated that this localiZed 
plant cell death aspect of the HR contains the invading 
microorganism or virus, thereby protecting the remainder of 
the plant. Other plant defenses include the production of 
phytoalexins (antibiotics) and/or lytic enZymes capable of 
averting pathogen ingress and/or cell Wall modi?cations 
Which strengthen the plant cell Wall against physical and/or 
enZymatic attack. 
The HR of plants, including tobacco, can include phy 
toalexin production as part of the response to invading 
microorganisms. One class of compounds made by tobacco 
(Nicotiana tabacum) in response to microbial invaders are 
the antimicrobial sesquiterpenes. 
Cell suspension cultures have provided useful informa 
tion regarding the regulation of terpene synthesis. Iso 
prenoids are ubiquitous in nature, and the early portions of 
the biosynthetic pathWay are shared With the biosynthetic 
pathWay for other isoprenoid compounds such as sterols, 
carotenoids, dolichol, and ubiguinone and groWth regulators 
(e.g., gibberellic acid), Which are classi?ed as primary 
metabolites. Isoprenoid compounds classi?ed as secondary 
metabolites are not essential for groWth, and include mono-, 
sesqui-, and diterpenoids. These secondary metabolite iso 
prenoids are important mediators of interactions betWeen the 
plant and its environment. 
A variety of compositions can serve as elicitors of plant 
phytoalexin synthesis. These include, but are not limited to, 
one or more toxic ions, e.g., mercuric ions, other chemically 
de?ned compositions, metabolic inhibitors, cell Wall 
glycans, certain glycoproteins, certain enZymes, fungal 
spores, chitosans, certain fatty acids, and certain oligosac 
charides derived from plant cell Walls [See, e.g., Sequeira, L. 
(1983) Annu. Rev. Microbiol. 37:51—79 and references cited 
therein]. Epi-5-aristolochene synthase (EAS) activity in 
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tobacco plants has been shoWn to be induced by cell Wall 
fragments of certain Phytophthora species and by Tricho 
derma viride cellulase but not Aspergillus japonicum pec 
tolyase [Chappell et al. (1991) Plant Physiol. 97:693—698]. 
Attack by other plant pathogens or an avirulent related strain 
can also induce phytoalexin synthesis; for example, 
Pseudomonas lachrymans induces sesquiterpenoid synthe 
sis in tobacco [Guedes et al. (1982) Phytochemistry 
21:2987—2988]. 
Elicitins are proteins Which are produced by plant patho 
gens and potential plant pathogens, Which proteins induce 
the HR in tobacco plants. Amino acid and nucleotide coding 
sequences for an elicitin of Phytophthora parasitica have 
been published [Kamoun et al. (1993) Mol. Plant-Microbe 
Interactions 6:573—581]. Plant pathogenic viruses including, 
but not limited to, Tobacco Mosaic Virus (TMV) induce the 
HR in infected plants. Bacteria Which infect plants also can 
induce HR and thereby disease resistance; representative 
bacteria eliciting HR include, but are not limited to, Agro 
bacterium species, Xanthomonas species and Pseudomonas 
syringae. Plant pathogenic fungi (and certain avirulent 
strains as Well) also induce the HR response, Where these 
include, but are not limited to, Phytophthora parasitica and 
Peronospora tabaci. 
When tobacco cell suspension cultures are treated With an 
elicitor, squalene synthetase is suppressed, thus stopping the 
How of common biosynthetic precursors into sterols. The 
concomitant induction of sesquiterpene cyclase gene expres 
sion causes the How of precursors into sesquiterpenes. The 
?rst step in the pathWay from farnesyl diphosphate to the 
sesquiterpene phytoalexin capsidiol in elicitor-induced 
tobacco tissue is catalyZed by 5-epi-aristolochene synthase 
(EAS), a sesquiterpene cyclase. The coding sequence and 
deduced amino acid sequence for one member of the EAS 
gene family of tobacco have been published [Facchini and 
Chappell (1992) Proc. Natl. Acad. Sci. USA 
89:11088—11092]. The transcriptional expression of one or 
more members of the EAS gene family is induced in 
response to elicitors. 
There is a long felt need in the art for methods of 
protecting plants, particularly crop plants, from infection by 
plant pathogens, including but not limited to, phytopatho 
genic viruses, fungi and/or bacteria. Especially important 
from the standpoint of economics and environmental con 
cerns are biological or “natural” methods rather than those 
Which depend on the application of chemicals to crop plants. 
There is also a long felt need in the art for plant transcrip 
tional regulatory sequences for use in controlling the expres 
sion of heterologous DNA sequences in transgenic plants. 
SUMMARY OF THE INVENTION 
In general, the invention features a recombinant nucleic 
acid molecule that includes an inducible plant disease 
resistance regulatory element. Such a recombinant nucleic 
acid molecule is, in general, at least 80% identical to a 
naturally-occurring inducible plant disease-resistance regu 
latory element; that is, up to 20% of the base pairs of the 
reference DNA sequence can be replaced With an alternative 
basepair (e.g., G-C replaced With A-T, T-A, or C-G), pro 
vided that the transcription-promoting activity of the altered 
sequence is the same or greater than the reference sequence. 
In preferred embodiments, the recombinant nucleic acid 
molecule according to the invention is obtained from a gene 
encoding a terpene cyclase (e.g., a sesquiterpene cyclase). 
For example, the recombinant regulatory element of the 
invention is obtained from an epi-5-aristolochene synthase 
6,100,451 
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(EAS) gene that includes the nucleotide sequence shown in 
FIG. 3A (SEQ ID NO: 14) or an inducible plant disease 
resistance fragment thereof. In preferred embodiments, the 
recombinant nucleic acid molecule according to the inven 
tion has the nucleotide sequence shoWn in FIG. 3A (SEQ ID 
NO: 14). 
In other preferred embodiments, the nucleic acid mol 
ecules of the invention includes any of the folloWing 
sequences: nucleotides 463—473 of SEQ ID NO: 2; nucle 
otides 406—486 of SEQ ID NO: 2; nucleotides 463—572 of 
SEQ ID NO: 2; nucleotides 371—463 of SEQ ID NO: 2; and 
nucleotides 411—457 of SEQ ID NO: 2. 
In preferred embodiments, the recombinant nucleic acid 
molecule of the invention is obtained from a dicot (e.g., a 
member of the Solanaceae such as Nicotiana). In other 
preferred embodiments, the nucleic acid of the invention is 
obtained from a monocot; a gymnosperm; or a conifer. 
In yet other preferred embodiments, the nucleic acid 
molecule of the invention is genomic DNA; chemically 
synthesiZed DNA; or is a combination of genomic DNA and 
chemically-synthesized DNA; genomic DNA and cDNA; 
chemically-synthesized DNA and cDNA; or genomic DNA, 
cDNA, and chemically-synthesized DNA. 
In preferred embodiments, induction of the nucleic acid 
molecule of the invention is mediated by a plant pathogen 
such as a fungus (e.g., Phytophthora), a bacterium (e.g., 
Pseudomonas), or a virus (e.g., tobacco mosaic virus) as 
described herein. In other preferred embodiments, such 
induction is mediated by an elicitor (e.g., by fungal or 
bacterial elicitors). 
In another aspect, the nucleic acid molecule of invention 
is operably linked to and functions to regulate inducible 
transcription of nucleotide sequences encoding a heterolo 
gous polypeptide. Preferably, the heterologous polypeptide 
is capable of conferring disease-resistance to a plant. For 
example, the heterologous polypeptide may be an elicitin 
(e.g., a fungal elicitin such as the parAl polypeptide from 
Phytophthora, a bacterial elicitin such as harpin, or a phar 
maceutical polypeptide such as tissue plasminogen 
activator). Expression of such a heterologous polypeptide is 
mediated by one or more external agents (e.g., ethylene or 
methyl jasmonate). In other embodiments, the nucleic acid 
molecule of invention is capable of expressing the heterolo 
gous polypeptide in a cell-speci?c manner. 
In another aspect, the invention features a vector includ 
ing the nucleic acid molecule of the invention, a method of 
directing expression of a polypeptide by introducing the 
vector into a cell (e.g., a transgenic plant cell), and a cell 
containing the vector. 
In another aspect, the invention features a method of 
providing disease-resistance to a transgenic plant, the 
method including the steps of: (a) producing a transgenic 
plant cell including the nucleic acid of according to the 
invention integrated into the genome of the transgenic plant 
cell; and (b) groWing the transgenic plant from the plant cell 
Wherein the expression of the nucleic acid molecule accord 
ing to the invention confers disease-resistance to the trans 
genic plant. 
In preferred embodiments, the transgenic plant according 
to the methods of the invention is a dicot (e.g., is a member 
of the Solanaceae such as Nicotiana); a monocot; a gymno 
sperm; or a conifer. 
In another aspect, the invention features a method of 
increasing the transcriptional expression of a doWnstream 
DNA sequence in a transgenic plant cell, the method includ 
ing the steps of: (a) producing a transgenic plant cell 
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including the nucleic acid of invention positioned for 
increasing transcription of a doWnstream DNA sequence and 
integrated into the genome of the transgenic plant cell; and 
(b) groWing the transgenic plant from the plant cell. 
In addition to the above features, the present invention 
provides qualitative transcriptional regulatory sequences 
Which regulate doWnstream gene expression in plant tissue 
in response to one or more elicitors, other de?ned inducing 
compounds, or in response to the stress of an invading 
phytopathogen (the inducible transcription regulatory 
sequence) and quantitative transcription regulatory 
sequences Which increase the transcription of doWnstream 
sequences (the transcription-enhancing sequence). As spe 
ci?cally exempli?ed herein, these transcriptional regulatory 
sequences are found in nature upstream and operatively 
linked to the epi-5-aristolochene synthase gene (EAS4) of 
tobacco; When operatively linked to a coding sequence (and 
in the presence of an operatively linked promoter element, 
from the EAS4 gene or from a heterologous plant 
expressible gene) these sequences mediate the inducible 
transcriptional expression of that coding sequence When the 
plant or plant tissue is invaded by a potential phytopathogen 
(e.g., a virus, fungus or bacterium) or in response to elicitors 
such as T richoa'erma viride cellulase or plant or fungal cell 
Wall fragments for plants, plant tissue and/or plant suspen 
sion culture cells. That potential plant pathogen can be a 
virus including, but not limited to, tobacco mosaic virus or 
tobacco vein mottle virus; a bacterium including, but not 
limited to, Pseudomonas syringae, Xanthomonas campestris 
or Agrobacterium tumefaciens; or a fungus including, but 
not limited to, a species of Phytophthora (e.g., R parasitica) 
or Peronospora (e.g., R tabaci). The EAS4 promoter includ 
ing the inducible transcription regulatory element(s) and the 
transcription-enhancing sequence(s) are disclosed herein as 
SEQ ID NO:2. In SEQ ID NO:2, the CAAT-homologous 
sequence of the EAS4 promoter is located at nucleotides 513 
to 516, and the TATA-sequence motif is located at nucle 
otides 540 to 543. 
Examples of inducible transcriptional regulatory elements 
Within the N. tabacum EAS4 upstream sequence are from 
nucleotide 458 to nucleotide 473 of SEQ ID NO:2; from 
nucleotide 454 to 473; and from nucleotide 413 to 473 of 
SEQ ID NO:2. 
Another aspect of the present invention is the 
transcription-enhancing element derived from the EAS4 
promoter and promoter-associated sequences. When opera 
tively linked upstream of a initiation sequences and a 
heterologous DNA sequence to be expressed. 
Further aspects of the present invention are transgenic 
plant cells, plant tissues, and plants Which have been geneti 
cally engineered to contain and express a nucleotide 
sequence of interest, preferably a coding sequence, an 
antisense sequence, or other sequence under the regulatory 
control of the inducible transcription regulatory element. It 
is an object of this invention to provide the nucleotide 
sequences Which mediate the induction of the expression of 
a doWnstream coding sequence in response to elicitor 
exposure, potential phytopathogen invasion in a plant, or 
certain other exogenous inducing signals such as exposure to 
methyl jasmonate and ethylene. An exemplary elicitor 
inducible transcription regulatory element is that from the 5 ‘ 
?anking region of the EAS4 gene of Nicotiana tabacum; as 
speci?cally exempli?ed herein, this sequence is presented in 
SEQ ID NO:2 from nucleotide 410 to nucleotide 473. 
Equivalents of the exempli?ed nucleotide sequence are 
those nucleotide sequences Which similarly direct the induc 
tion of the expression of doWnstream nucleotide sequences. 
6,100,451 
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Preferably, the inducible transcription regulatory element is 
associated With the EAS4 promoter and promoter-associated 
sequences (e.g., the combination having the nucleotide 
sequence as given in SEQ ID NO:2 from nucleotide 410 to 
nucleotide 573 of SEQ ID NO:2, preferably from nucleotide 
361 to 573 of SEQ ID NO:2, and more preferably from 
nucleotide 1 to 573 of SEQ ID NO:2). 
By “disease-resistance regulatory element” is meant a 
DNA sequence capable of regulating the expression of a 
gene product associated With a plant defense response (e.g., 
a hypersensitive response) that, in a native plant, is used to 
a combat pathogenic organism. Also included in this term 
are regulatory elements (and, as de?ned beloW, fragments of 
such regulatory elements) that are sufficient to render gene 
expression inducible by disease-associated external signals 
or agents (e.g., pathogen- or elicitor-induced signals or 
agents as described herein). In general, disease-resistance 
regulatory elements are located in the 5‘ region of a gene, but 
are not so limited. 
By “inducible” is meant that a regulatory element is 
capable of mediating increased gene expression (e.g., 
mRNA or polypeptide production) in response to an inter 
action betWeen a plant cell and either a pathogen or elicitor. 
Also included in the invention are disease-resistance regu 
latory elements that direct inducible gene expression in a 
cell- or tissue-speci?c manner. 
By “obtained from a gene” is meant that the nucleotide 
sequence of a regulatory element is based on sequence 
information included in a naturally-occurring plant gene 
(e.g., tobacco EAS4). Once identi?ed, the regulatory ele 
ment according to the invention is obtained from a natural 
source or can be prepared according to any standard method 
(e.g., by recombinant methods or chemical synthesis). Such 
a recombinant nucleic acid molecule is, in general, at least 
80% identical to a naturally-occurring inducible plant 
disease-resistance regulatory element; that is, up to 20% of 
the base pairs of the reference DNA sequence can be 
replaced With an alternative basepair (e.g., G-C replaced 
With A-T, T-A, or C-G), provided that the transcription 
promoting activity of the altered sequence is the same or 
greater than the reference sequence. 
By “an inducible plant disease-resistance fragment” is 
meant any stretch of nucleotides regardless of length, Which 
is suf?cient to direct increased gene expression (e.g., mRNA 
or polypeptide production) in response to an interaction 
betWeen a plant cell and either a pathogen or elicitor. The 
term “fragment” preferably means about 6—10 nucleotides in 
length. HoWever, fragments of DNA regulatory elements 
according to the invention can range in siZe from 10—100 
nucleotides, 100—300 nucleotides in length, or even greater 
than 300 nucleotides in length. Such fragments are prepared 
by routine methods (e.g., by appropriate restriction digestion 
or by chemical synthesis of the fragment). Identi?cation of 
an inducible plant disease-resistance DNA fragment in a 
gene is carried out using standard methods in the art (e.g., 
those methods described herein). In one particular example, 
identi?cation of an inducible plant disease-resistance frag 
ment may be carried out using standard promoter deletion 
analysis. Aconstruct including a disease-resistance promoter 
that confers pathogen-inducible transcription to a reporter 
gene to Which it is operably linked may be progressively 
deleted by 5‘, 3‘, and/or nested deletions until the effect of a 
pathogen on the reporter gene is diminished or eliminated. 
To con?rm the identi?cation of the pathogen-inducible 
element, point mutations may then be introduced into the 
element. An alternate approach to guage changes in tran 
scription is to link the presumed regulatory element from the 
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gene to the reporter gene. To test for complete promoters, the 
DNA fragment is placed directly in front of the reporter gene 
lacking endogenous promoter activity. Using such 
techniques, any fragment of an inducible plant disease 
resistance regulatory element may be identi?ed. 
By “tissue-speci?c” is meant capable of preferentially 
increasing expression of a gene product (e.g., an mRNA 
molecule or polypeptide) in one tissue (e. g., xylem tissue) as 
compared to another tissue (e.g., phloem). 
By “cell-speci?c” is meant capable of preferentially 
increasing expression of a gene product (e.g., an mRNA 
molecule or polypeptide) in one cell (e.g., a parenchyma 
cell) as compared to another cell (e.g., an epidermal cell). 
By “epi-5-aristocholene synthase” or “EAS” is meant an 
enZyme capable of catalyZing the cycliZation of trans, trans 
farnesyl diphosphate to the bicyclic intermediate epi-5 
aristocholene. 
By “pathogen” is meant an organism Whose infection into 
the cells of viable plant tissue elicits a disease response in 
the plant tissue. 
By “elicitor” is meant any molecule that is capable of 
initiating a plant defense response. Examples of elictors 
include, Without limitation, one or more toxic ions, e.g., 
mercuric ions, other chemically de?ned compositions, meta 
bolic inhibitors, cell Wall glycans, certain glycoproteins, 
certain enzymes, fungal spores, chitosans, certain fatty 
acids, and certain oligosaccharides derived from plant cell 
Walls, and elicitins (e.g., harpin, cryptogein, and pariscein). 
By “elicitin” is meant a protein elicitor. 
By “operably linked” is meant that a regulatory sequence 
(s) and a gene are connected in such a Way as to permit gene 
expression When the appropriate molecules (e.g., transcrip 
tional activator proteins) are bound to the regulatory 
sequence(s). 
By “heterologous polypeptide” is meant any polypeptide 
that is expressed in a transformed plant cell from a gene that 
is partly or entirely foreign (i.e., does not naturally occur in) 
to the transformed plant cell. 
By “polypeptide” is meant any chain of amino acids, 
regardless of length or post-translational modi?cation (e.g., 
glycosylation or phosphorylation). 
By “transformed plant cell” is meant a cell into Which (or 
into an ancestor of Which) a recombinant nucleotide 
sequence (e.g., the EAS4 promoter(—1147 to +67): GUS 
reporter gene or gEAS46O0(cyclase) promoter:parA1 mature 
elicitin gene) has been introduced by means of recombinant 
DNA techniques (e.g., those techniques described herein). 
By “plant cell” is meant any self-propagating cell 
bounded by a semi-permeable membrane and containing a 
plastid. Such a cell also requires a cell Wall if further 
propagation is desired. Plant cell, as used herein includes, 
Without limitation, algae, cyanobacteria, seeds, suspension 
cultures, embryos, meristematic regions, callus tissue, 
leaves, roots, shoots, gametophytes, sporophytes, pollen, 
and microspores. 
By “transgenic” is meant any cell Which includes a DNA 
sequence Which is inserted by arti?ce into a cell and 
becomes part of the genome of the organism Which develops 
from that cell. As used herein, the transgenic organisms are 
generally transgenic plants, and the DNA is inserted by 
arti?ce into the genome of the organism. 
By “substantially pure DN ” is meant DNA that is free of 
the genes or ancillary nucleotides Which, in the naturally 
occurring genome of the organism from Which the DNA of 
the invention is derived, ?ank the gene or regulatory ele 
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ment. The term therefore includes, for example, a recombi 
nant DNA Which is incorporated into a vector; into an 
autonomously replicating plasmid or virus; or into the 
genomic DNA of a prokaryote or eukaryote; or Which exists 
as a separate molecule (e.g., a cDNA or a genomic or cDNA 
fragment produced by PCR or restriction endonuclease 
digestion) independent of other sequences. It also includes a 
recombinant DNA Which is part of a hybrid gene encoding 
an additional polypeptide sequence or a regulatory element. 
Other features and advantages of the invention Will be 
apparent from the folloWing description of the preferred 
embodiments thereof, and from the claims. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 presents data for transient expression experiments 
for GUS regulated by the EAS3 and EAS4 promoter region 
sequences in comparison to a CaMV 35S-GUS construct 
(Cauli?ower Mosaic Virus 35S promoter—[3-glucuronidase 
reporter gene). These experiments Were carried out in 
tobacco protoplasts into Which the DNA constructs had been 
electroporated. “Uninduced” levels of expression for the 
EAS-GUS constructs Were relatively high because fungal 
enZymes Which digest plant cell Walls Were used in the 
preparation of the protoplasts. The y-axis shoWs units of 
GUS activity and the 5‘ extents of the EAS upstream 
sequences are given beloW each bar on the graph. As above, 
the numbering is relative to the natural transcription start site 
of EAS4 (or the corresponding base of EAS3); in EAS4 
(SEQ ID NO:2) a start site is at nucleotide 573; in EAS3 
(SEQ ID NO:1) a potential transcription start site is at 
nucleotide 489. 
FIGS. 2A—2B present information concerning the reporter 
gene expression directed by the instant inducible transcrip 
tion regulatory element of the invention. FIG. 2A presents a 
schematic of experiments carried out With the EAS4 pro 
moter region controlling the expression of the GUS reporter 
gene in stably transformed transgenic plants. FIG. 2B pre 
sents the results of “gain of function” assays for the EAS4 
promoter-associated sequences regulating expression of the 
GUS reporter gene via the CaMV 35S minimal promoter. In 
both FIGS. 2A and 2B, numbering for the EAS4 upstream 
region re?ects numbering relative to the natural transcription 
start site of the EAS4 gene (see also SEQ ID NO:2 Wherein 
the transcription start site corresponds to nucleotide 573). In 
both FIGS. 2A and 2B, the GUS expression is measured in 
?uorescence units per milligram of protein. 
FIGS. 3A—3B are schematic illustrations shoWing the 
DNA sequence of the 5‘ upstream region of the EAS4 gene 
and the structure of the GUS reporter gene carrying the 
EAS4 promoter(—1148 to +67). FIG. 3A shoWs the nucle 
otide sequence of the 5‘ upstream region of the EAS4 
promoter (-1148 to +67). The CAAT and TATA boxes are 
marked in bold face. The transcription initiation site is 
marked as +1. FIG. 3B is a schematic illustration shoWing 
the structure of the EAS4 promoter(—1148 to +67): GUS 
reporter gene. The 5‘ ?anking sequence of the EAS4 pro 
moter (-1148 to +67) Was fused in correct reading frame 
With the GUS reporter gene in binary vector pBI101.1. 
FIGS. 4A—4B present data concerning elicitor-induced 
GUS gene expression in leaves, stems, and roots of trans 
genic tobacco plants containing the EAS4(—1148 to +67): 
GUS reporter gene. FIG. 4A is a graph illustrating elicitor 
induced GUS activity in tobacco leaves over an 18 hour time 
course. 06i, 08r, and 09p each represent an independently 
transformed line of transgenic tobacco containing the EAS4 
promoter(—1148 to +67): GUS reporter gene construct. 
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Water (as control) and 25 nM of cryptogein Were in?ltrated 
symmetrically and simultaneously into the leaf (abaxially), 
and the in?ltrated Zones of leaf tissue Were then collected for 
analysis of GUS activity over the 18 hour time course. The 
presented data are the averaged results of tWo separate 
experiments. FIG. 4B is a bar graph shoWing elicitor 
induced GUS activity in the stems and roots of transgenic 
tobacco containing the EAS4 promoter(—1148 to +67): GUS 
reporter gene. 03f and 09p represent tWo independently 
transformed lines of transgenic tobacco. C-O (open boxes) 
represents GUS activity present in segmented roots and 
stems Without elicitor treatment. C-18 (shaded boxes) and 
E-18 (solid boxes) represent GUS activity in segmented 
roots and stems 18 hours after an incubation in Water or 100 
nM of elicitor cryptogein, respectively. Five independent 
plants Were evaluated per transgenic line. 
FIG. 5 is a bar graph illustrating pathogen-induced GUS 
activity by race 0 and race 1 of Phytophthora parasitica var. 
Nicotianae in transgenic tobacco. Detached leaves from one 
line of transgenic tobacco (09p) containing the EAS4 
promoter(—1148 to +67): GUS reporter gene Were inocu 
lated With mycelial plugs of 2-day-old P. p. var. Nicotianae 
cultures and then incubated in a groWth chamber at 27° C. 
With constant ?uorescent light for 24 hours. Control leaves 
Were inoculated With sterile oatmeal agar plugs. Infected 
Zones of tissue Were then examined for GUS activity. Values 
indicated by each bar are the means and standard errors for 
three separate experiments (n=5). 
FIG. 6 is a bar graph illustrating the comparison of 
pathogen- and elicitor-induced GUS activity in transgenic 
plants treated With Pseudomonas Syringae pv. Syringae 61 
and its hrpH mutant, and the puri?ed bacterial elicitor 
protein harpin. Leaves of one line of transgenic tobacco 
(09-P) containing the EAS4 promoter(—1148 to +67): GUS 
reporter gene Were in?ltrated With either 50 pg/mL of 
puri?ed Erwinia amylovora harpin elicitor, cell suspensions 
of Wild type R Syringae pv. Syringae 61 or its hrpH mutant 
(A6OO=0.05). After a 12 hour incubation, in?ltrated Zones of 
tissue Were subsequently analyZed for GUS activity. Control 
values represent GUS activity observed in leaf tissue 
samples Which Were in?ltrated With Water. Values indicated 
by each bar are the average of results obtained from ?ve 
plants. 
FIGS. 7A—7B shoW a Western blot analysis of induction 
of 5-epi-aristolochene synthase (EAS) in tobacco plant 
tissues. Proteins Were extracted from control- and elicitor 
treated tobacco leaves, stems, and roots. Equal guantities of 
proteins (25 pg per lane for leaf and stem, 15 pg per lane for 
root) Were separated by SDS-PAGE and transferred to 
nitrocellulose membranes. The blots Were then reacted With 
EAS antiserum and immunoreactive bands visualiZed using 
goat anti-mouse antibodies coupled to alkaline phosphatase. 
FIG. 7A shoWs the Western blot analysis of leaf and stem 
tissue samples. FIG. 7B shoWs the Western blot analysis of 
root tissue samples. 
FIGS. 8A—8L are color photographs illustrating the his 
tochemical localiZation of elicitor-induced GUS activity in 
transgenic tobacco containing the EAS4 promoter(—1147 to 
+67): GUS reporter gene. Leaf tissues from one represen 
tative line of transgenic tobacco Were in?ltrated With either 
25 or 50 nM of the cryptogein elicitor. After an approxi 
mately 8 hour incubation, tissue sections Were stained using 
1 mM X-gluc(5-bromo-4-chloro-3-indoyl [3-glucuronide) 
for analysis of GUS activity. Stem and root segments Were 
incubated With Water or 100 nM of the elicitor cryptogein for 
approximately 12 hours before staining. FIG. 8A is a color 
photograph shoWing elicitor-induced GUS activity in a 
6,100,451 
transgenic tobacco leaf containing the EAS4 promoter(— 
1147 to +67): GUS reporter gene after treatment With tWo 
elicitor preparations: cryptogein and parasicein, both at 
concentrations of 25 nM and 50 nM (designated in FIG. 8A 
as C25, C50, P25, and P50, respectively). FIG. 8B is a color 
photograph of a leaf cross-section shoWing elicitor-induced 
GUS activity after treatment With cryptogein (magni?cation, 
75x). FIG. 8C is a color photograph shoWing elicitor 
induced GUS activity in a cross-section of a stem segment 
treated With cryptogein (magni?cation, 7.5x). FIGS. 8D—F 
are color photographs shoWing successively higher magni 
?cations (15x, 60x, and 75x, respectively) of the GUS 
stained stem cross-section shoWn in FIG. 8C. FIG. 8G is a 
color photograph shoWing a root tip treated With Water and 
stained for GUS activity (magni?cation, 60x). FIG. 8H is a 
color photograph shoWing elicitor-induced GUS activity of 
a longitudinal section of a root tip treated With cryptogein 
(magni?cation, 60x). FIG. SI is a color photograph of a 
longitudinal section of a root after treatment With Water and 
staining for GUS activity (magni?cation, 75x). FIG. SJ is a 
color photograph shoWing GUS activity of a longitudinal 
section of a root treated With cryptogein (magni?cation, 
75x). FIG. 8K is a color photograph of a root cross-section 
treated With Water and staining for GUS activity 
(magni?cation, 95x). FIG. SL is a color photograph shoWing 
GUS activity of a cross section of a root treated With 
cryptogein (magni?cation, 95x). C, denotes cryptogein; P, 
denotes parasicein; c, denotes corteX; ca, denotes cambium; 
e, denotes epidermis; p, denotes palisade parenchyma; pe, 
denotes periderm; ph, denotes phloem; pi, denotes pith 
parenchyma; s, denotes spongy parenchyma; t, denotes 
trichome; X, denotes Xylem; vc, denotes vascular cylinder. 
FIG. 9 is a schematic of the genetic manipulations leading 
to generation of disease-resistant plants. The coding 
sequence for the ParA1 elicitin is isolated by PCR so as to 
have BamHI and SstI ends. gEAS46OO-GUS-pBI101, Which 
directs the eXpression of the GUS reporter gene under the 
regulatory control of the EAS promoter, is digested With 
BamHI and SstI to release the GUS reporter gene. Then the 
BamHI/SstI-digested parA1 amplimer is ligated to the large 
fragment produced after digestion of gEAS46O0-GUS 
pBI101 to produce gEAS46O0-parA1-pBI101, from Which 
the ParA1 elicitin in plant cells or plant tissue is synthesiZed 
after induction With a suitable elicitor. 
FIG. 10 is a bar graph illustrating the disease ratings of 
independent lines of transgenic tobacco (Nicotiana tabacum 
cv. KY160) containing either the parA1 mature elicitin gene 
under the control of the gEAS46OO<CWlaSe> promoter gene 
after inoculation of detached leaves With either race 0 or race 
1 of Phytophthora parasitica var. nicotianae. The y-aXis 
shoWs the lesion score (number of lesions per leaf) after 72 
hours. The X-aXis shoWs control plants and independent lines 
of transgenic tobacco Which Were tested for disease resis 
tance. KY160 denotes non-transformed N. tabacum cv. 
KY160; G denotes independent lines of transgenic N. 
tabacum cv. KY160 Which Were transformed With a con 
struct containing the gEAS46OO<CWlaSe> promoter fused to 
GUS; M denotes independent lines of transgenic N. tabacum 
cv. KY160 Which Were transformed With a construct con 
taining the gEAS460O<CWlaS€> promoter fused to the mature 
parA1 elictin coding sequence; S denotes independent lines 
of transgenic N. tabacum cv. KY160 Which Were trans 
formed With a construct containing the gEAS460O<CWlaS€> 
promoter fused to a sequence encoding a mature parA1 
elictin including a signal sequence. Shaded boX, denotes 
inoculation of detached leaf With race 0 of P. p. var. 
nicotianae. Solid boX denotes inoculation of detached leaf 
With race 1 of P. p. var. nicotianae. 
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DETAILED DESCRIPTION OF THE 
INVENTION 
5 -epi-aristolochene synthase (EAS) is a key enZyme in the 
synthesis of sesquiterpenoid phytoaleXins, for example, in 
solanaceous plants, including but not limited to Nicotiana 
species (e.g., tabacum), Capsicum annum and Hyoscyamus 
muticus. EAS catalyZes the reaction of farnesyl diphosphate 
to (+) gemacrene A to eudesmane carbocation to 5-epi 
aristolochene. Other plants, such as the crucifers, also have 
sesquiterpene cyclase enZymes. 
Treatments Which induce host defensive responses in 
plant tissue or plant cells such as phytoaleXin synthesis 
include cell Wall fragments of Phytophthora species and 
Trichoderma viride cellulase. HoWever, pectolyase from 
Aspergillus japonicum does not function as an elicitor in 
tobacco cell culture. Elicitors Which induce sesquiterpenoid 
phytoaleXin synthesis have been shoWn to function at the 
level of controlling transcription of key biosynthetic 
enZymes [Vogeli and Chappell (1990) Plant Physiol. 
94:1860—1866]. Similar patterns have been observed in 
other plants, but no transcriptional control sequences Which 
mediate gene induction in response to phytopathogen chal 
lenge have been described. 
Tobacco (N. tabacum) contains an EAS gene family With 
some 12—15 members, the coding sequence of EAS4 has 
been published [Facchini and Chappell (1992) supra]. 
HoWever, since that time, the present inventors have dis 
covered that the EAS3 does not appear to be expressed in 
response to the elicitor treatment, and surprisingly, the 
nucleotide sequences upstream of EAS3 do not appear to 
mediate the induction of a reporter gene in a chimeric gene 
construct in elicitor-induced transgenic cell culture. It is 
noted that the translation start site Was incorrectly identi?ed 
in the 1992 Facchini and Chappell publication. The nucle 
otide sequence of a genomic clone of EAS4, as it appears in 
Facchini and Chappell (1992) supra is presented in SEQ ID 
NO:7, With the deduced amino acid sequence being given in 
SEQ ID NO:8. 
Other aspects of a plant’s defenses against invasion and 
infection by a phytopathogenic microorganism include the 
hypersensitive response, Which is characteriZed by necrosis, 
i.e., programmed cell death in the localiZed area of attack by 
the plant pathogen. Elicitor treatments as described above 
can also induce the necrotic response. 
Elicitins are proteins produced by fungal plant pathogens, 
Which proteins elicit a hypersensitive response in an infected 
plant. Generally, but not necessarily, localiZed cell death is 
the result of the elicitin-induced response in the infected (or 
challenged) plant tissue. These responses mediate full or 
partial resistance to destructive infection by the invading, 
potentially plant pathogenic microorganism. For the pur 
poses of the present invention, a protein of a plant pathogen 
or potential plant pathogen Which induces the hypersensitive 
response in plant tissue after invasion of that plant tissue or 
after eXpression of that coding sequence in the plant tissue 
is considered to fall Within a broad de?nition of an elicitin. 
A relatively Well-knoWn elicitin of a plant-pathogenic 
fungus is the ParA1 protein of Phytophthora parasitica. The 
parA1 locus is a member of a gene family [Ricci et al. (1989) 
Eur J. Biochem. 183:555—563]. The coding and amino acid 
sequences for the parA1 gene product are described in 
Kamoun et al. (1993) Mol. Plant-Microbe Interact. 6:(5): 
573-14 581 and in SEQ ID NOS:12 and 13 herein. 
Other phytopathogen proteins With potential elicitin activ 
ity have been characteriZed as to amino acid sequences and 
other properties [See, e.g., Nespoulous et al. (1992) Planta 
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186155 1—557; Huet et al. (1992) Phytochemistry 
31:1471—1476; Huet and Pernollet (1992) FEBS Lett. 
257:302—306; Kamoun et al. (1993) Mol. Plant-Microbe 
Interact. 5:22—33]. Several avirulent genes from pathogenic 
bacteria Which correspond to elicitin activity have been 
characterized. For example, Keen, N. T. (1990) Annu. Rev. 
Phytopathol. 24:383—409 has described an avirulence gene 
of Fulva fulvia. Hammond-Kosack et al. (1994) Proc. Natl. 
Acad. Sci. USA 91:10445—10449 have described the avr 
gene of Cladosporium fulvum, Which functions in the same 
Way as the R parasitica elicitin. 
Certain bacterial plant pathogens also express proteins 
With similar effects on the hypersensitivity response as those 
of the R parasitica ParA1 elicitin. For the purposes of the 
present invention, these proteins fall Within the scope of the 
term “elicitin.” Multiple homologs of the avirulence gene 
avrBs3 of Xanthomonas campestris pv. vesicatoria have 
been detected in otherX. campestris pathovars [Bonas et al. 
(1989) Mol. Gen. Genet. 218:127—136; Knoop et al. (1991) 
J. Bacteriol. 173:7142—7150] and in other species of Xan 
thomonas [De Feyter and Gabriel (1991) Mol. Plant 
Microbe Interact. 4:423—432; Hopkins et al. (1992) Mol. 
Plant-Microbe Interact. 5:451—459]. The avrD gene of 
Pseudomonas syringae pv. tomato can confer avirulence; R 
syringae pv. glycinea expresses an altered avrD gene prod 
uct [Kobayashi et al. (1990) Mol. Plant-Microbe Interact. 
3:103—111]. 
It is understood that to be useful in the present invention 
as it applies to creating transgenic plants With improved 
disease resistance traits using an elicitin coding sequence 
expressed under the regulatory control of a pathogen 
response transcription regulatory element (and With a mini 
mal promoter functional in those plants) that elicitin proteins 
must be capable of promoting expression of defense genes 
(including but not limited to those genes governing phytoal 
exin synthesis, the hypersensitive response and/or localiZed 
necrosis) in those plants. Many functional combinations of 
plant and phytopathogen are knoWn to the art, and the skilled 
artisan knoWs hoW to test the functioning of a particular 
elicitin in a particular plant tissue (or cells) in the turning on 
of programmed cell death or phytoalexin synthesis or the 
like. It is also understood that treatment of plant cells or 
tissue With compositions such as certain fungal cellulases or 
certain plant polysaccharide fragments can also induce the 
host defensive (i.e., hypersensitive) response. Such treat 
ments are used as models for actual plant pathogen attack or 
invasion. 
A non-naturally occurring recombinant nucleic acid 
molecule, e.g., a recombinant DNA molecule, is one Which 
does not occur in nature; i.e., it is produced either by natural 
processes using methods knoWn to the art, but is directed by 
man to produce a desired result or it has been arti?cially 
produced from parts derived from heterologous sources, 
Which parts may be naturally occurring or chemically syn 
thesiZed molecules or portions thereof, and Wherein those 
parts have been joined by ligation or other means knoWn to 
the art. 
A transgenic plant is one Which has been genetically 
modi?ed to contain and express heterologous DNA 
sequences, either as regulatory RNA molecules or as pro 
teins. As speci?cally exempli?ed herein, a transgenic plant 
is genetically modi?ed to contain and express a heterologous 
DNA sequence operably linked to and under the regulatory 
control of transcriptional control sequences by Which it is 
not normally regulated, i.e., under the regulatory control of 
the inducible transcriptional control sequences of the EAS4 
gene of Nicotiana tabacum. As used herein, a transgenic 
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plant also refers to those progeny of the initial transgenic 
plant Which carry and are capable of expressing the heter 
ologous coding sequence under the regulatory control of the 
qualitative and/or quantitative transcription control 
sequences described herein. Seeds containing transgenic 
embryos are encompassed Within this de?nition. 
When production of a heterologous gene or coding 
sequence of interest is desired under conditions of potential 
pathogen invasion or inducer (e.g., elicitor) treatment, that 
coding sequence is operably linked in the sense orientation 
to a suitable promoter and under the regulatory control of the 
inducible regulatory sequences, in the same orientation as 
the promoter, so that a sense (i.e., functional for translational 
expression) mRNA is produced. A transcription termination 
signal functional in a plant cell can be placed doWnstream of 
the coding sequence, and a selectable marker Which can be 
expressed in a plant, can be covalently linked to the induc 
ible expression unit so that after this DNA molecule is 
introduced into a plant cell or tissue, its presence can be 
selected and plant cells or tissue not so transformed Will be 
killed or prevented from groWing. Similarly, a heterologous 
coding sequence can be expressed under the regulatory 
control of the inducible transcription regulatory element or 
the transcription-enhancing element in transgenic plant cell 
suspension culture, With induction occurring in response to 
the addition of an elicitor to the cell culture medium. 
Where inhibition of gene expression is desired in a plant 
being invaded by a microbial pathogen, such as a phyto 
pathogenic fungus, then either a portion or all of that coding 
sequence or cDNA sequence can be operably linked to a 
promoter functional in plant cells, but With the orientation of 
the coding sequence opposite to that of the promoter (i.e., in 
the antisense orientation) so that the transcribed RNA is 
complementary in sequence to the mRNA, and so that the 
expression of the antisense molecule is induced in response 
to pathogen invasion. In addition, there may be a transcrip 
tional termination signal doWnstream of the nucleotides 
directing synthesis of the antisense RNA. 
The present inventors have isolated a DNA sequence 
Which mediates the inducible expression of a doWnstream 
gene in plant cells in response to invasion by a potential 
plant pathogen and/or treatment With an elicitor or other 
chemical signals. For example, a combination of ethylene 
and methyl jasmonate may serve to induce doWnstream gene 
expression via the qualitative transcription regulatory 
sequence. It is understood that there may be a multiplicity of 
sequence motifs Within that regulatory sequence, Where 
individual motifs each respond to one or more distinct 
environmental signal. As speci?cally exempli?ed, this 
transcription-regulating sequence is derived from the EAS4 
locus of N. tabacum, and it is given in SEQ ID NO:7. The 
deduced amino acid sequence for the EAS protein is given 
in SEQ ID NO:8. The open reading frame of the EAS4 gene, 
Which is interrupted by six introns, is provided in SEQ ID 
NO:7. 
A computer search of Genbank for nucleotide sequences 
homologous to the SEQ ID NO:2 sequence revealed no 
knoWn nucleotide sequences With signi?cant homology. 
Organization of the EAS genes in the N. tabacum genome 
Was described in Facchini and Chappell (1992) supra using 
an EAS probe and Southern hybridiZation experiments. 
Under conditions of high stringency, multiple fragments 
hybridiZed With analysis indicating that there is a gene 
family With some 12—16 members in the tobacco genome. In 
these experiments, hoWever, the probe included the EAS 
coding sequence rather than the promoter and promoter 
associated regulatory sequences. 
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EAS homologous genes can be identi?ed and isolated 
from plant species other than N. tabacum based on signi? 
cant degrees of nucleotide sequence homology; i.e., 
DNAzDNA hybridization under conditions of moderate to 
high stringency With a tobacco EAS coding sequence probe 
alloWs the identi?cation of the corresponding gene from 
other plant species. A discussion of hybridiZation conditions 
can be found for example, in Hames and Higgins (1985) 
Nucleic Acid Hybridization, IRL Press, Oxford, UK. Gen 
erally sequences Which have at least about 70% nucleotide 
sequence homology can be identi?ed by hybridiZation under 
conditions of moderate stringency. Under such conditions, it 
is generally preferred that a probe of at least 100 bases be 
used. Most preferably, in the present case, the probe Will be 
derived from the coding portion of the EAS4 coding 
sequence. Labels for hybridiZation probes can include, but 
are not limited to, radioactive groups, ?uorescent groups, 
and ligands such as biotin to Which speci?c binding partners 
(Which are in turn labeled) bind. It is the label Which alloWs 
detection of the hybridiZation probe to the target nucleic acid 
molecule. Alternatively, Well-knoWn and Widely accessible 
polymerase chain reaction (PCR) technology is advanta 
geously used to amplify sequences With signi?cant nucle 
otide sequence homology to a target sequence. 
It is understood that nucleic acid sequences other than the 
EAS coding sequence disclosed in SEQ ID NO:7 Will 
function as coding sequences synonymous With the exem 
pli?ed EAS4 coding sequence. Nucleic acid sequences are 
synonymous if the amino acid sequences encoded by those 
nucleic acid sequences are the same. The degeneracy of the 
genetic code is Well-knoWn to the art; i.e., for many amino 
acids, there is more than one nucleotide triplet Which serves 
as the codon for the amino acid. It is also Well-knoWn in the 
biological arts that certain amino acid substitutions can be 
made in protein sequences Without affecting the function of 
the protein. Generally, conservative amino acid substitutions 
or substitutions of similar amino acids are tolerated Without 
affecting protein function. Similar amino acids can be those 
that are similar in siZe and/or charge properties, for example, 
aspartate and glutamate and isoleucine and valine are both 
pairs of similar amino acids. Similarity betWeen amino acid 
pairs has been assessed in the art in a number of Ways. For 
example, Dayhoff et al. (1978) in Atlas of Protein Sequence 
and Structure, Vol. 5, Suppl. 3, pp. 345—352, Which is 
incorporated by reference herein, provides frequency tables 
for amino acid substitutions Which can be employed as a 
measure of amino acid similarity. Dayhoff et al.’s frequency 
tables are based on comparisons of amino acid sequences for 
proteins having the same function from a variety of evolu 
tionarily different sources. 
Terpene cyclase genes can be found in solanaceous plants, 
including N. tabacum and Hyoscyamus muticus, as disclosed 
herein, and in members of the mint family (Labitaceae) and 
the Euphorbiaceae, including but not limited to those Which 
have been demonstrated to contain sequences of signi?cant 
homology, and in substantially all plants. Preferably, EAS4 
homologs Will be selected from the Solanaceae. Such 
sequences can be identi?ed by nucleic acid hybridiZation 
experiments or When cloned in expression vectors, by cross 
reaction to tobacco EAS-speci?c antibody, or any other 
means knoWn to the art, including the use of PCR technol 
ogy carried out using oligonucleotides corresponding to 
portions of SEQ ID NO:7, preferably in the region encoding 
EAS. Antibody can be prepared after immuniZing an experi 
mental animal With EAS puri?ed as described in Vogeli et al. 
(1990) Plant Physiology 93:182—187 or using a peptide 
conjugate, Where the amino acid sequence of the peptide is 
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taken from a hydrophilic portion of the EAS amino acid 
sequence (SEQ ID NO:8). Monoclonal and polyclonal anti 
body production techniques are readily accessible to the art 
(See, e.g., Campbell (1994) Monoclonal Antibody Technol 
ogy. Laboratory Techniques in Biochemistry and Molecular 
Biology, Vol. 13, Burdon and Knippenberg, eds, Elsevier, 
Amsterdam; HarloW and Lane (1988) Antibodies: A Labo 
ratory Manual, Cold Spring Harbor Laboratory, Cold Spring 
Harbor, 
Alternately, a cDNA library (in an expression vector) can 
be screened With EAS-speci?c antibody, or EAS peptide 
speci?c antibody can be prepared using peptide sequence(s) 
from hydrophilic regions of the EAS protein (SEQ ID NO:8) 
and technology Well-knoWn in the art. 
An inducible transcription regulatory sequence can be 
operably linked to any promoter sequence functional in 
plants as understood by the skilled artisan; Where a regula 
tory element is to be coupled to a promoter, generally a 
truncated (or minimal) promoter is used, for example, the 
truncated 35S promoter of Cauli?oWer Mosaic Virus, 
CaMV). Truncated versions of other constitutive promoters 
can also be used to provide CAAT and TATA-homologous 
regions; such promoter sequences can be derived from those 
of A. tumefaciens T-DNA genes such as nos, ocs, and mas 
and plant virus genes such as the CaMV 19S gene. It Will be 
understood that the goals of a skilled artisan Will determine 
the choice of particular promoters used With the inducible 
transcription regulatory sequences. It is further understood 
that When a protein capable of generating a cell death 
response is to be expressed, then there is preferably no basal 
transcriptional (and translational) expression in the absence 
of inducer. The minimiZation of basal expression is less 
critical in applications for inducible gene expression Where 
the gene product has no signi?cant toxicity to the plant cells 
producing it. 
A minimal promoter contains the DNA sequence signals 
necessary for RNA polymerase binding and initiation of 
transcription. For RNA polymerase II promoters, the pro 
moter is identi?ed by a TATA-homologous sequence motif 
about 20 to 50 bp upstream of the transcription start site and 
a CAAT-homologous sequence motif about 50 to 120 bp 
upstream of the transcription start site. By convention, the 
skilled artisan often numbers the nucleotides upstream of the 
transcription start With increasingly large numbers extend 
ing upstream of (in the 5‘ direction) from the start site. 
Generally, transcription directed by a minimal promoter is 
loW and does not respond either positively or negatively to 
environmental or developmental signals in plant tissue. An 
exemplary minimal promoter suitable for use in plants is the 
truncated CaMV 35S promoter, Which contains the regions 
from —90 to +8 of the 35S gene. 
The inducible transcription regulatory sequence 
(qualitative transcription regulatory sequence) is localiZed to 
the region betWeen —167 and —100 relative to the EAS4 
transcription initiation site (nucleotides 406 to 473, initiation 
at nucleotide 573 in SEQ ID NO:2). It is understood that 
there may be a plurality of sequence motifs Which respond 
to particular stimuli. Operably linking this sequence directly 
upstream of a minimal promoter functional in a plant cell 
confers inducible expression of a coding sequence operably 
fused just doWnstream of the promoter, e.g., a heterologous 
coding sequence, and the skilled artisan understands spacing 
requirements and other requirements for translational 
expression of the coding sequence. The heterologous coding 
sequence is preferably for an elicitin-like protein of a plant 
pathogenic microorganism (e.g., a virus, bacterium or 
fungus), for example, the sequence encoding the parA1 gene 





















